Abbott Laboratories to pay $670 million to settle cases, claims over its formula for premature babies

Abbott Laboratories has agreed to pay $670 million to settle a high-profile lawsuit and claims made on behalf of thousands of others related to allegations that its formula for babies born prematurely causes a dangerous intestinal disease.